Chris Langmead Email
Chief Scientific Officer and Co-Founder @ Phrenix Therapeutics
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Chris Langmead Location
- Parkville, VIC, AU
Chris Langmead Work
- Chief Scientific Officer and Co-Founder @ (June 2026 - Present)
- Chief Executive Officer and Co-Founder @ (July 2022 - June 2026)
- Professor, Neuromedicines Discovery Centre @ (April 2025 - Present)
- Professor and Director, Neuromedicines Discovery Centre @ (August 2023 - April 2025)
- Professor and Deputy Director, Neuromedicines Discovery Centre @ (November 2021 - August 2023)
- Honorary Fellow @ (January 2026 - Present)
- Co-Lead, Neuroscience and Mental Health Therapeutic Program Area @ (January 2020 - July 2022)
- Head, Servier Drug Discovery Program @ (June 2012 - April 2025)
- Fellow @ (January 2011 - December 2025)
- Chief Scientific Advisor and Co-Founder @ (July 2023 - January 2026)
- Head of Pharmacology @ (February 2009 - May 2012)
- Guest Lecturer @ (January 2010 - January 2012)
- Team Leader, Biochemical Pharmacology @ (October 2006 - January 2009)
- Principal Scientist @ (October 1998 - October 2006)
Chris Langmead Education
- UCL
PhD (Molecular Pharmacology)
2000-2005 - University of Cambridge
BA (Hons) (Natural Sciences)
1995-1998
Chris Langmead Skills
- Cell
- Lead Optimization
- Neuropharmacology
- ADME
- Electrophysiology
- Customer Service
- Pharmacokinetics
- Cell Biology
- High Throughput Screening
- Biochemistry
- Neuroscience
- Lead Change
- Cell Based Assays
- Life Sciences
- Lifesciences
- Assay Development
- In Vitro
- Clinical Development
- Drug Discovery
- Molecular Pharmacology
- Lecturing
- In Vivo
- Medicinal Chemistry
- Patch Clamp
- Project Management
- Biotechnology
- Cell Culture
- Pharmaceutical Research
- CRO
- Stem Cells
- Leadership
- Team Leadership
- Pharmacology
- GPCRs
- Pharmacodynamics
- Drug Development
- Strategy
- Animal Models
- Protein Chemistry
Chris Langmead Summary
- Chris Langmead, based in Parkville, VIC, AU, is currently a Chief Scientific Officer and Co-Founder at Phrenix Therapeutics. Chris Langmead brings experience from previous roles at Phrenix Therapeutics and Monash University. Chris Langmead holds a 2000 - 2005 PhD in Molecular Pharmacology @ UCL. With a robust skill set that includes Cell, Lead Optimization, Neuropharmacology, ADME, Electrophysiology and more. Chris Langmead has 2 emails on RocketReach.
Looking for a different Chris Langmead?
Find contact details for 700 million professionals.
Others Named Chris Langmead
Chris Langmead
Vice President of Global Supply Chain
San Diego, CA, US
Christopher Langmead
Vice President, AI-Driven Molecular Design
Monroeville, PA, US
Top Phrenix Therapeutics Employees
Chris Langmead
Chief Scientific Officer and Co-Founder
Parkville, VIC, AU
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co